Development and Validation of a Clinical Model to Predict the Presence of β-Lactam Resistance in Viridans Group Streptococci Causing Bacteremia in Neutropenic Cancer Patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.